FitFlow review

FitFlow publishes more than a headline for its two main wellness injectables: sermorelin is $175 for the first month and $200 on renewal, while NAD⁺ is $165 then $190. Its glutathione page conflicts with itself, showing $110 in the hero and $299 in the pricing tab. The medical group and fifty-state list are named, but the dispensing pharmacy and individualized supply are not.

FitFlow, trading as FitFlow Health, is a 100% online telehealth platform organized around weight loss, strength, anti-aging, hair growth and mood. Its named products include compounded semaglutide and tirzepatide, sermorelin, an NAD⁺ injection, an NAD⁺ facial cream, glutathione and MIC+B12, with hair and sexual-health lines alongside. Intake is an online questionnaire reviewed by a provider from Wasef Health, an independent medical group it names; its about page gives a 24 to 48-hour review window. Medication ships free from a licensed U.S. compounding pharmacy. It advertises FSA/HSA eligibility, financing through Affirm, Klarna and Afterpay, 24/7 provider messaging, same-day doctor visits and a LegitScript certification, and publishes a list of all 50 states it serves.

FitFlow uses an online questionnaire, review by Wasef Health and home delivery. Its about page gives a 24 to 48-hour review window, while shorter same-day phrasing appears elsewhere. All fifty states are listed, subject to clinical review. No pharmacy is named, and a routine lab bundle is not disclosed for sermorelin; ask which tests the selected plan requires or includes. The refund policy allows a refund before pharmacy submission or after medical ineligibility; once sent to the pharmacy, a prescription cannot be canceled for a refund. Subscription cancellation requires contact and confirmation, effective at cycle end without a prorated refund. Damage or missing delivery must be reported within 24 hours with evidence.

Sermorelin is advertised at $175 for the first month, then $200 a month, with supplies and expedited shipping included. NAD⁺ injection is $165 for the first month, then $190, also with a home kit and expedited shipping. The page lists vial details but does not establish an individualized monthly quantity. Glutathione conflicts: $110 a month in its hero and $299 in the active pricing tab, with no explanation for the difference. The $99 semaglutide and $134 tirzepatide monthly equivalents require annual prepayment of $1,188 and $1,608; they are separate GLP-1 offers. Confirm selected product, dose, first charge and renewal before paying.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. FitFlow discloses the compounded status of its medications and says they are prepared by licensed U.S. compounding pharmacies, but names none, and compounded sterile products are not reviewed by FDA for purity and potency the way approved drugs are. On the evidence, the priced peptides sit at different places and the site does not distinguish them. Sermorelin is a GHRH analog acting on the growth-hormone axis — a real, well-described mechanism — but long-term human outcome data stays thin and no controlled trial demonstrates the body-composition, recovery or anti-aging results the category is marketed on. NAD⁺ by injection is weaker still: no controlled human outcome trials exist for it at all, and the single human intravenous study was a pharmacokinetic pilot finding that infused NAD⁺ clears from plasma quickly. The NAD⁺ forms with human data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker rather than a demonstrated clinical benefit — and the NAD⁺ facial cream FitFlow also sells has no outcome evidence behind it whatsoever. Glutathione is in the same position. On the GLP-1 side, compounded semaglutide and tirzepatide target well-studied pathways but the compounded preparations are not themselves FDA-approved or therapeutically equivalent to Wegovy, Ozempic, Zepbound or Mounjaro. Individual results vary.